miR- 26a Sensitizes Melanoma Cells To Dabrafenib Via Targeting HMGB1-Dependent Autophagy Pathways
Yan Yu,1,* Niu Xiang,2,* Min Lin,2 Jin-Wen Huang,2 Jing Zhang,2 Bo Cheng,2 Chao Ji2 1Department of Dermatology, First Hospital of Jilin University, Changchun, Jilin 130021, People’s Republic of China; 2Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, F...
Main Authors: | Yu Y, Xiang N, Lin M, Huang JW, Zhang J, Cheng B, Ji C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-10-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/mir--26a-sensitizes-melanoma-cells-to-dabrafenib-via-targeting-hmgb1-d-peer-reviewed-article-DDDT |
Similar Items
-
Endoplasmic reticulum stress-induced autophagy determines the susceptibility of melanoma cells to dabrafenib
by: Ji C, et al.
Published: (2016-08-01) -
Endoplasmic Reticulum Stress-Induced Autophagy Determines the Susceptibility of Melanoma Cells to Dabrafenib [Retraction]
by: Ji C, et al.
Published: (2023-06-01) -
Successful Dabrafenib Desensitization Protocols in a Patient with Metastatic Melanoma
by: Roxana Silvia Bumbacea, et al.
Published: (2022-04-01) -
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma
by: David Balakirouchenane, et al.
Published: (2020-04-01) -
Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib
by: Valpione Sara, et al.
Published: (2015-03-01)